Page 2 - ஸ்தாபனம் ஆய்வகம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஸ்தாபனம் ஆய்வகம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஸ்தாபனம் ஆய்வகம் Today - Breaking & Trending Today

Establishment Labs to Announce Fourth Quarter 2020 Financial Results on March 10


Posted on
210
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, plans to announce its financial results for the quarter ended December 31, 2020 before the market opens on Wednesday, March 10, 2021, and will host a conference call at 8:30 am ET that day to discuss those results.
To participate in the conference call, dial (877) 376-9925 (U.S. and Canada) or (629) 228-0732 (International) and use conference ID number 5664669. The call will also be available via live or archived webcast on the “Investor Relations” section of the Establishment Labs website at www.establishmentlabs.com. ....

United States , Establishment Labs Holdings Inc , Establishment Lab , Establishment Labs Holdings , Establishment Labs , Labs Holdings , Motiva Implants , Motiva Implant , Simulation System , ஒன்றுபட்டது மாநிலங்களில் , ஸ்தாபனம் ஆய்வகங்கள் ஹோல்டிங்ஸ் இன்க் , ஸ்தாபனம் ஆய்வகம் , ஸ்தாபனம் ஆய்வகங்கள் ஹோல்டிங்ஸ் , ஸ்தாபனம் ஆய்வகங்கள் , ஆய்வகங்கள் ஹோல்டிங்ஸ் , உந்துதல் உள்வைப்புகள் , உந்துதல் உள்வைப்பு , உருவகப்படுத்துதல் அமைப்பு ,

Establishment Labs Completes 21 Motiva Mia Patients in IRB Approved Study in Costa Rica


Published: Dec 10, 2020
SANTA BARBARA, Calif., Dec. 10, 2020 (GLOBE NEWSWIRE) Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced it recently received Institutional Review Board (IRB) approval to initiate a patient series in Costa Rica to study its Motiva Mia
® system for minimally invasive augmentation, which includes the Motiva Ergonomix2 Diamond
® breast implant, and has completed the procedure in the first 21 patients in the study.
“Motiva Mia is truly disruptive to traditional breast aesthetics,” said Dr. Charles Randquist, an internationally recognized plastic surgeon. “Minimally invasive breast enhancement should define a more balanced approach in aesthetics: an augmentation that is considerably more subtle in its sizing and approach and is performed without general anesthesia through a very small incision with ....

United States , Costa Rica , Davidk Erickson , Pablo Sol , Manuel Chac , Juan Jos , Alexandre Munhoz , Charles Randquist , Exchange Commission , Establishment Labs Holdings Inc , Securities Exchange , Establishment Lab , Paulo School Of Medicine , Labs Holdings , Institutional Review Board , Motiva Ergonomix , Paulo School , Motiva Mia , Motiva Implants , Establishment Labs , Motiva Implant , Simulation System , Securities Act , Securities Exchange Act , Private Securities Litigation Reform Act , Media Contact ,